Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten J Postma

Showing results (141-150 of 485) with videos related to

Pageof 49
Sort By:
Reproductive Biomedicine Online|October 29, 2011
The long-term fiscal impact of funding cuts to Danish public fertility clinicsMark P Connolly, Maarten J Postma, Simone Crespi, et al.
Plos One|February 12, 2025
Accuracy of the Modified Finnish Diabetes Risk Score (Modified FINDRISC) for detecting metabolic syndrome: Findings from the Indonesian national health surveyIndriastuti Cahyaningsih, M Rifqi Rokhman, Sudikno, et al.
Sexually Transmitted Infections|January 25, 2019
Systematic review and evidence synthesis of non-cervical human papillomavirus-related disease health system costs and quality of life estimatesKoh Jun Ong, Marta Checchi, Lorna Burns, et al.
Journal of Bone and Mineral Metabolism|April 12, 2013
Persistence with osteoporosis medication among newly-treated osteoporotic patientsJob F M van Boven, Pieter T de Boer, Maarten J Postma, et al.
Journal of Medical Economics|May 9, 2012
Economic evaluation of dabigatran etexilate for the primary prevention of venous tromboembolic events following major orthopedic surgery in the NetherlandsMaarten J Postma, Bregt S Kappelhoff, Marinus van Hulst, et al.
Journal of Medical Economics|March 27, 2013
Author response : economic evaluation of dabigatran etexilateMaarten J Postma, Bregt S Kappelhoff, Marinus van Hulst, et al.
Vaccine|December 17, 2008
Cost-effectiveness of a potential future Helicobacter pylori vaccine in the Netherlands: the impact of varying the discount rate for healthRobin de Vries, Rogier M Klok, Jacobus R B J Brouwers, et al.
Plos One|March 25, 2016
Multivariate Meta-Analysis of Preference-Based Quality of Life Values in Coronary Heart DiseaseJelena Stevanović, Petros Pechlivanoglou, Marthe A Kampinga, et al.
Journal of Infection and Public Health|January 31, 2024
Comprehensive childhood vaccination and its determinants: Insights from the Indonesia Family Life Survey (IFLS)Rano K Sinuraya, Sofa D Alfian, Rizky Abdulah, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|September 25, 2023
Differences in evidentiary requirements for oncology drug effectiveness assessments among six European health technology assessment bodies - can alignment be improved?Sharon Wolters, Lisa A de Jong, Christel Jansen, et al.
Pageof 49

Showing results (141-150 of 485) with videos related to

Sort By:
Pageof 49
Reproductive Biomedicine Online|October 29, 2011
The long-term fiscal impact of funding cuts to Danish public fertility clinicsMark P Connolly, Maarten J Postma, Simone Crespi, et al.
Plos One|February 12, 2025
Accuracy of the Modified Finnish Diabetes Risk Score (Modified FINDRISC) for detecting metabolic syndrome: Findings from the Indonesian national health surveyIndriastuti Cahyaningsih, M Rifqi Rokhman, Sudikno, et al.
Sexually Transmitted Infections|January 25, 2019
Systematic review and evidence synthesis of non-cervical human papillomavirus-related disease health system costs and quality of life estimatesKoh Jun Ong, Marta Checchi, Lorna Burns, et al.
Journal of Bone and Mineral Metabolism|April 12, 2013
Persistence with osteoporosis medication among newly-treated osteoporotic patientsJob F M van Boven, Pieter T de Boer, Maarten J Postma, et al.
Journal of Medical Economics|May 9, 2012
Economic evaluation of dabigatran etexilate for the primary prevention of venous tromboembolic events following major orthopedic surgery in the NetherlandsMaarten J Postma, Bregt S Kappelhoff, Marinus van Hulst, et al.
Journal of Medical Economics|March 27, 2013
Author response : economic evaluation of dabigatran etexilateMaarten J Postma, Bregt S Kappelhoff, Marinus van Hulst, et al.
Vaccine|December 17, 2008
Cost-effectiveness of a potential future Helicobacter pylori vaccine in the Netherlands: the impact of varying the discount rate for healthRobin de Vries, Rogier M Klok, Jacobus R B J Brouwers, et al.
Plos One|March 25, 2016
Multivariate Meta-Analysis of Preference-Based Quality of Life Values in Coronary Heart DiseaseJelena Stevanović, Petros Pechlivanoglou, Marthe A Kampinga, et al.
Journal of Infection and Public Health|January 31, 2024
Comprehensive childhood vaccination and its determinants: Insights from the Indonesia Family Life Survey (IFLS)Rano K Sinuraya, Sofa D Alfian, Rizky Abdulah, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|September 25, 2023
Differences in evidentiary requirements for oncology drug effectiveness assessments among six European health technology assessment bodies - can alignment be improved?Sharon Wolters, Lisa A de Jong, Christel Jansen, et al.
Pageof 49